Current Policies
WMA's policies on ethical and social issues
Title | Tags | Year | Type | |
---|---|---|---|---|
WMA Statement on Environmental Degradation and Sound Management of Chemicals | Chemicals, Chemicals Management, Environment, Environmental Degradation, Plastic bags, Plastic wastes | 2010 | Statement | |
WMA Resolution on Drug Precsription | Delegation, Diagnosis, Drug Prescription, Patient Safety, Pharmaceutical Products, Prescription, Scope of Practice, Substitution | 2010 | Resolution | |
WMA Statement on Family Violence | Abuse, Family Violence, Maltreat, Neglect, Prevention, Reporting, Violence | 2010 | Statement | |
WMA Statement on the Relationship between Physicians and Pharmacists in Medicinal Therapy | Delegation, Drug Therapy, Medical Therapy, Pharmacists, Professional Responsibility, Scope of Practice, Substitution | 2010 | Statement | |
WMA Statement on Medical Care for Migrants | Access to Health Care, Asylum Seekers, Medical Care, Migrants, Refugees | 2010 | Statement | |
WMA Statement on Violence against Women | Advocacy, Domestic Violence, Family Violence, Girls, Violence, Women | 2010 | Statement | |
WMA Declaration of Ottawa on Child Health | Adolescent, Assent, Child, Development, Education, Environment, Growth, Ottawa, Parents, Patient/Physician-Relationship, Privacy | 2009 | Declaration, Declaration of Ottawa | |
WMA Declaration of Delhi on Health and Climate Change | Adaptation, Climate, Delhi, Environment, Environmental Footprint, Global Warming, Mitigation, Natural Catastrophe, Pandemic, UN | 2009 | Declaration | |
WMA Resolution on Medical Workforce | Attrition, Education, Human Resources for Health, Resilience, Resource Allocation, Retention, Scope of Practice, Task Shifting, Training, Workforce, Working Conditions | 2009 | Resolution | |
WMA Statement on Stem Cell Research | Adult Stem Cells, ASC, Embryonic Stem Cells, ES, Ethical Dilemma, Stem Cell | 2009 | Statement | |
WMA Statement on Digital Health | Confidentiality, Consent, Digital Health, Duties, E-health, Mobile health, Outcomes, Patient/Physician-Relationship, Rules, Safety, Security, Telehealth, Telematics, Telemedicine | 2009 | Statement | |
WMA Declaration of Reykjavik – Ethical Considerations Regarding the Use of Genetics in Health Care | Bio Patents, Confidentiality, Consent, Intellectual Property, Patenting, Pharmacokinetics, Predictive Medicine, Substance Patents | 2009 | Declaration | |
WMA Statement concerning the Relationship between Physicians and Commercial Enterprises | Affiliation, CME, Commercial Companies, Conferences, Conflict of Interest, Cooperation, Corporate Relations, CPD, Disclosure, Education, Gifts, Grants, Independence, Influence, Integrity, Research, Sponsoring, Transparency | 2009 | Statement | |
WMA Statement on Patenting Medical Procedures | Affordability, Innovation, Intellectual Property, Medical Process Patent, Patent, Transparency | 2009 | Statement | |
WMA Declaration on Guidelines for Continuous Quality Improvement in Healthcare | Assessment, Audits, CME, CPD, Data, Patient Safety, Quality Management, Standards | 2009 | Declaration |